Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Zollinger-Ellison Syndrome 1Stomach Ulcer 1Pancreatic Neoplasms 1Esophagitis, Peptic 1Adenocarcinoma 1

Interventions

Esomeprazole 3(2-(1R)-1-cyclopropyl)ethyl-6-isopropyl-phenol 2Tumor Necrosis Factor-alpha 1Tetracycline 1Propofol 1Physical Examination 1Omeprazole 1Lansoprazole 1Interleukin-10 1Interleukin-1 1Gastroscopy 1Furazolidone 1Endoscopy, Digestive System 1Endoscopy 1Dexlansoprazole 1Clopidogrel 1Bismuth 1Berberine 1Amoxicillin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Stomach Ulcer × Clopidogrel × Gastrointestinal × Clear all
NCT00942175 2012-02-03

A Study of the Effects of Multiple Doses of Dexlansoprazole, Lansoprazole, Omeprazole or Esomeprazole on the Pharmacokinetics and Pharmacodynamics of Clopidogrel in Healthy Participants.

Takeda

Phase 1 Completed
160 enrolled 16 charts
Gastrointestinal

Esophagitis, Peptic, Stomach Ulcer, Zollinger-Ellison Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡